Neuberger Berman High Yield Strategies Fund Past Earnings Performance
Past criteria checks 2/6
Neuberger Berman High Yield Strategies Fund's earnings have been declining at an average annual rate of -20.9%, while the Capital Markets industry saw earnings growing at 9.7% annually. Revenues have been declining at an average rate of 4.9% per year. Neuberger Berman High Yield Strategies Fund's return on equity is 1.9%, and it has net margins of 16.6%.
Key information
-20.9%
Earnings growth rate
-18.2%
EPS growth rate
| Capital Markets Industry Growth | 10.3% |
| Revenue growth rate | -4.9% |
| Return on equity | 1.9% |
| Net Margin | 16.6% |
| Last Earnings Update | 31 Oct 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Neuberger Berman High Yield Strategies Fund makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Oct 23 | 22 | 4 | 3 | 0 |
| 31 Jul 23 | 22 | -1 | 2 | 0 |
| 30 Apr 23 | 21 | -6 | 2 | 0 |
| 31 Jan 23 | 19 | -20 | 2 | 0 |
| 31 Oct 22 | 18 | -33 | 2 | 0 |
| 31 Jul 22 | 16 | -25 | 2 | 0 |
| 30 Apr 22 | 15 | -16 | 3 | 0 |
| 31 Jan 22 | 16 | 5 | 3 | 0 |
| 31 Oct 21 | 16 | 27 | 3 | 0 |
| 31 Jul 21 | 18 | 44 | 3 | 0 |
| 30 Apr 21 | 19 | 62 | 3 | 0 |
| 31 Jan 21 | 20 | 32 | 3 | 0 |
| 31 Oct 20 | 22 | 3 | 4 | 0 |
| 31 Jul 20 | 22 | -12 | 4 | 0 |
| 30 Apr 20 | 22 | -27 | 4 | 0 |
| 31 Jan 20 | 23 | -2 | 4 | 0 |
| 31 Oct 19 | 24 | 23 | 3 | 0 |
| 31 Jul 19 | 23 | 20 | 3 | 0 |
| 30 Apr 19 | 23 | 17 | 3 | 0 |
| 31 Jan 19 | 23 | 7 | 3 | 0 |
| 31 Oct 18 | 22 | -3 | 3 | 0 |
| 31 Jul 18 | 23 | 0 | 3 | 0 |
| 30 Apr 18 | 23 | 3 | 3 | 0 |
| 31 Jan 18 | 23 | 14 | 3 | 0 |
| 31 Oct 17 | 23 | 24 | 3 | 0 |
| 31 Jul 17 | 24 | 31 | 3 | 0 |
| 30 Apr 17 | 24 | 39 | 3 | 0 |
| 31 Jan 17 | 24 | 33 | 3 | 0 |
| 31 Oct 16 | 24 | 27 | 3 | 0 |
| 31 Jul 16 | 24 | 7 | 3 | 0 |
| 30 Apr 16 | 24 | -14 | 3 | 0 |
| 31 Jan 16 | 25 | -14 | 3 | 0 |
| 31 Oct 15 | 25 | -14 | 3 | 0 |
| 31 Jul 15 | 26 | -5 | 3 | 0 |
| 30 Apr 15 | 26 | 5 | 3 | 0 |
| 31 Jan 15 | 27 | 10 | 3 | 0 |
| 31 Oct 14 | 27 | 16 | 3 | 0 |
| 31 Jul 14 | 27 | 19 | 3 | 0 |
| 30 Apr 14 | 27 | 21 | 3 | 0 |
| 31 Jan 14 | 27 | 28 | 3 | 0 |
| 31 Oct 13 | 27 | 34 | 3 | 0 |
| 31 Jul 13 | 27 | 41 | 3 | 0 |
Quality Earnings: NHS has a large one-off loss of $7.6M impacting its last 12 months of financial results to 31st October, 2023.
Growing Profit Margin: NHS became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NHS has become profitable over the past 5 years, growing earnings by -20.9% per year.
Accelerating Growth: NHS has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: NHS has become profitable in the last year, making it difficult to compare its past year earnings growth to the Capital Markets industry (3.3%).
Return on Equity
High ROE: NHS's Return on Equity (1.9%) is considered low.